Irreversible peptide ligands for bombesin receptors, their use, and process for making the same
US5100873A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 17, 1989 |
| Grant date | Mar 31, 1992 |
| Priority date | — |
| Expiry date | Jul 17, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peptide of formula (I): EQU A-B-C-D-Gln-Trp-Ala-Val-X-Y-T-W (I) wherein either: PA0 (i) A represents a hydrogen atom, a Boc group or an acetyl group, one of B and C represents a pMel or mMel residue, and the other of B and C represents a sigma bond or a Gly, Leu-Gly, E-Leu-Gly or Gln-E-Leu-Gly, E, or E-Gly residue with E=Arg(A), arg(A), Lys(A), lys(A), Orn(A) and orn(A); or PA0 (ii) A represents a hydrogen atom; PA0 B represents a Glp-Arg-Leu-Gly residue; PA0 C represents a pMel or mMel residue; PA0 D represents a sigma bond or an Asn or Thr residue; PA0 X represents a Gly or ala residue; PA0 Y represents a sigma bond or a His(R.sub.1); PA0 his(R.sub.1), Phe, phe, Ser, ser, Ala or ala residue, PA0 T represents a sigma bond or a Leu, leu, Phe or phe residue; PA0 W represents an OH, amino, pentylamino or phenethyl-amino group or a Met-R.sub.2, Leu-R.sub.2, Ile-R.sub.2 or Nle-R.sub.2 residue; PA0 R.sub.1 represents a hydrogen atom or a Tos, Dnp or Bzl group; and PA0 R.sub.2 represents an amino, hydroxy, methoxy or hydrazino group; and its pharmaceutically acceptable salts are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.